Search results for "From ACP Internist Weekly"


 
Results 1 - 10 of about 36 for "From ACP Internist Weekly".

Expert panel recommends SGLT2 inhibitor or GLP-1 receptor agonist for patients with type 2 diabetes and CVD

pathway from the American College of Cardiology. ... All articles from the December 14, 2018, ACP Diabetes Monthly Newsletter.
December 2018

New guideline offers recommendations for older patients with diabetes or prediabetes

a reduction in the minimum estimated glomerular filtration rate at which dapagliflozin may be prescribed from 60 mL/min/1.73 m. ... All articles from the April 5, 2019, ACP Diabetes Monthly Newsletter.
April 2019

Diabetes Collaborative Registry seeks primary care participants

ACP has partnered with the American College of Cardiology to participate in the Diabetes Collaborative Registry, a national clinical diabetes registry and interdisciplinary collaboration designed to assess and improve the quality ... ACP has partnered
August 2015

Kidney failure, CV events lower with canagliflozin than placebo, industry study finds

stage kidney disease, doubling of creatinine, or death from renal causes) (HR, 0.66; 95% CI, 0.53 to 0.81; P < 0.001) with the drug. ... All articles from the May 10, 2019, ACP Diabetes Monthly Newsletter.
May 2019

SGLT2 inhibitors associated with rare, life-threatening necrotizing genital infections

Twelve patients were men and seven were women, with an age range from 42 to 79 years. ... All articles from the May 10, 2019, ACP Diabetes Monthly Newsletter.
May 2019

Lower glucose levels before hospital discharge associated with readmission, death in diabetes patients

Similarly, the event rate ratio for mortality within 180 days increased from 1.07 with a minimum glucose level of 80 to 89 mg/dL (4.4 to 4.9 ... All articles from the May 10, 2019, ACP Diabetes Monthly Newsletter.
May 2019

Newer, older insulin formulations may offer similar glucose-lowering effects

Glargine, 300 U/mL (Glar-300), had a favorable weight profile compared with degludec, 100 U/mL (Deg-100); degludec, 200 u/mL (Deg-200); thrice-weekly degludec (Deg-3TW); glargine, ... wrote. All articles from the July 13, 2018, ACP Diabetes Monthly
July 2018

Task Force recommends screening for type 2 diabetes in overweight, obese adults

To update this recommendation, the USPSTF commissioned an evidence review that was published online April 14 by Annals of Internal Medicine and covered in the April 14 ACP Internist Weekly. ... All articles from the November 13, 2015, ACP Diabetes
November 2015

Preoperative factors may help predict long-term weight outcomes after gastric bypass, study finds

Using electronic health records from 1 health system, researchers followed 726 patients (mean age, 45.2 years; 83.1% women) for 7 to 12 years after Roux-en-Y gastric bypass ... All articles from the September 16, 2016, ACP Diabetes Monthly Newsletter.
September 2016

Diabetes outcomes similar when primary care provided by NPs, PAs, or physicians, study finds

Researchers from the Durham VA Medical Center in North Carolina used electronic health record data, which included 568 VA primary care facilities and 368, 481 adult patients with diabetes, to compare ... All articles from the December 14, 2018, ACP
December 2018

Result Page: Prev   1   2   3   4   Next